Pages that link to "Q73288184"
Jump to navigation
Jump to search
The following pages link to Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade (Q73288184):
Displaying 50 items.
- Regulation of hyaluronidase activity by alternative mRNA splicing (Q24300353) (← links)
- Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer (Q24307419) (← links)
- HYAL1 overexpression is correlated with the malignant behavior of human breast cancer (Q24313097) (← links)
- Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis (Q24321280) (← links)
- Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter (Q24329200) (← links)
- Marine Origin Polysaccharides in Drug Delivery Systems (Q26767227) (← links)
- Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene (Q29347539) (← links)
- Separation of hyaluronic acid by ultrahigh-voltage capillary gel electrophoresis (Q33213959) (← links)
- Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer. (Q33648449) (← links)
- HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer (Q33688043) (← links)
- Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand? (Q33915293) (← links)
- The role of angiogenesis in prostate and other urologic cancers: a review (Q33955367) (← links)
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis (Q34512129) (← links)
- Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat (Q34541867) (← links)
- The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder (Q34999699) (← links)
- Current bladder cancer tests: unnecessary or beneficial? (Q35192390) (← links)
- Non-invasive methods of bladder cancer detection (Q35782279) (← links)
- Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer (Q35837359) (← links)
- Alternatives to cytology in the management of non-muscle invasive bladder cancer (Q35876409) (← links)
- ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. (Q36040206) (← links)
- Urine telomerase for diagnosis and surveillance of bladder cancer. (Q36134957) (← links)
- Heme oxygenase-1 in tumors: is it a false friend? (Q36174178) (← links)
- Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis (Q36190604) (← links)
- Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers (Q36363221) (← links)
- Urothelial cancer biomarkers for detection and surveillance (Q36418389) (← links)
- Molecular markers in bladder cancer: a critical appraisal (Q36526271) (← links)
- Urinary bladder tumor markers (Q36669984) (← links)
- Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests (Q36770389) (← links)
- Hyaluronan and hyaluronidase in genitourinary tumors (Q37072219) (← links)
- Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma. (Q37142553) (← links)
- Hyalurondiase: both a tumor promoter and suppressor (Q37151526) (← links)
- Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer (Q37406847) (← links)
- Molecular screening for bladder cancer: progress and potential. (Q37671590) (← links)
- Diagnosis and Management of Urothelial Carcinoma of the Bladder (Q37874887) (← links)
- Targeting hyaluronic acid family for cancer chemoprevention and therapy (Q38235792) (← links)
- Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression (Q38320495) (← links)
- Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence (Q39254195) (← links)
- Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation. (Q40538801) (← links)
- Dietary supplement hymecromone and sorafenib: a novel combination for the control of renal cell carcinoma (Q41412192) (← links)
- Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates (Q42814705) (← links)
- Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma (Q44062356) (← links)
- Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer. (Q44204551) (← links)
- Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome (Q44427704) (← links)
- Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? (Q47281580) (← links)
- The expression and significance of survivin mRNA in urinary bladder carcinomas (Q47616737) (← links)
- Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets. (Q47874868) (← links)
- Autodisplay of Human Hyaluronidase Hyal-1 on Escherichia coli and Identification of Plant-Derived Enzyme Inhibitors. (Q52862618) (← links)
- Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma (Q63533784) (← links)
- The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer (Q73352495) (← links)
- Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests (Q74455549) (← links)